Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
Conclusion Pre-therapy with ADV or ETV followed by PEG-IFN alfa-2a is not superior to PEG-IFN alfa-2a monotherapy in Taiwanese patients with HBeAg-positive CHB. Clinical trial ID NCT: 00922207.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Clinical Trials | General Medicine | Hepatitis | Hepatitis B | Pegasys | Study | Taiwan Health